Vital Farms Inc
For the period ended Sep 29, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 29, 2024 · Filed Nov 7, 2024
VITL$10.01-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
| 39-Weeks Ended | ||
|---|---|---|
| September 29,2024 | September 24,2023 | |
| Cash flows from operating activities: | ||
| Net income | $42,808 | $18,356 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation | 6,978 | 5,595 |
| Reduction in the carrying amount of right-of-use assets | 5,644 | 2,787 |
| Amortization of available-for-sale debt securities | 96 | 341 |
| Amortization of debt issuance costs | 39 | — |
| Stock-based compensation expense | 7,572 | 5,502 |
| Deferred taxes | (267) | 1,082 |
| Unrealized loss on derivative instruments | 394 | 761 |
| Other | 926 | 363 |
| Net change in operating assets and liabilities | (14,147) | (7,610) |
| Net cash provided by operating activities | $50,043 | $27,177 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (10,482) | (9,138) |
| Purchases of available-for-sale debt securities | — | (982) |
| Purchases and settlements of derivative instruments | (669) | (1,264) |
| Sales of available-for-sale debt securities | — | 2,895 |
| Maturities and call redemptions of available-for-sale debt securities | 19,505 | 25,228 |
| Proceeds from the sale of property, plant and equipment | 1 | 1,056 |
| Return of investment in variable interest entity | — | 552 |
| Net cash provided by investing activities | $8,355 | $18,347 |
| Cash flows from financing activities: | ||
| Proceeds from borrowing under revolving line of credit | — | 7,500 |
| Proceeds from exercise of stock options | 11,305 | 396 |
| Proceeds from issuance of common stock under employee stock purchase plan | 178 | 135 |
| Repayment of revolving line of credit | — | (7,500) |
| Payment of tax withholding obligation on vested restricted stock unit shares | (1,493) | (668) |
| Principal payments under finance lease obligations | (2,589) | (1,491) |
| Payment of financing costs | (414) | — |
| Net cash provided by (used in) financing activities | $6,987 | $(1,628) |
| Net increase in cash and cash equivalents | 65,385 | 43,896 |
| Cash and cash equivalents at beginning of the period | 84,149 | 12,914 |
| Cash and cash equivalents at end of the period | $149,534 | $56,810 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $732 | $507 |
| Cash paid for income taxes | $12,873 | $3,189 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchases of property, plant and equipment included in accounts payable and accrued liabilities | $433 | $667 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.